The International Master of Science in Paediatric Medicines Development and Evaluation awarded by the University of Rome “Tor Vergata” School of Paediatrics in collaboration with the Children’s Hospital Bambino Gesù and the EU Project Global Research in Paediatrics (GRiP) has been officially kicked-off on November 19th, 2014.

The MSc Programme on Paediatric Medicines Development and Evaluation is a two-year programme with 60 ECTS, based on ten modules to be taken in a sequenced manner. The Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) and the Gianni Benzi Pharmacological Research Foundation (FGB) are responsible for the production of educational materials of one of the ten modules.

Almost all theoretical education is offered online through the GRiP Virtual Learning Environment and students are required to attend face-to-face lessons during the Fresher’s and Re-Fresher’s meetings and during their work placement and/or training stages.

18 students from 10 different countries – 8 of them from non-EU countries – have been enrolled and they are currently working or studying in Italy, Kenia, Belgium, Denmark, Germany, Hungary, Congo, Malta, Spain and Switzerland.

On 19-21 November the students met in Rome to formally begin the programme, which from then on will be taught entirely online and will provide them with the tools to become internationally-recognised experts in the development and evaluation of paediatric medicines, according to GRiP’s core knowledge and values.

More information about the MSc programme, are available on the link below:

GRiP Master of Science in Paediatric Medicines and Evaluation.